Table 1. Significantly enriched pathways involving DEGs following DADS treatment.
| Pathway | DEGs with pathway annotation (%) | All genes with pathway annotation (%) | Q-value | Pathway ID | |
|---|---|---|---|---|---|
| Le4h vs. Le0h | Glutathione metabolism | 28 (8.56%) | 101 (2.3%) | 3.68E-08 | ko00480 |
| Plant hormone signal transduction | 43 (13.25%) | 262 (5.97%) | 1.66E-05 | ko04075 | |
| Plant-pathogen interaction | 30 (9.17%) | 155 (3.53%) | 2.23E-05 | ko04626 | |
| Cysteine and methionine metabolism | 16 (4.89%) | 83 (1.89%) | 7.39E-03 | ko00270 | |
| Le24h vs. Le0h | Plant hormone signal transduction | 38 (19.91%) | 262 (5.97%) | 9.27E-10 | ko04075 |
| Plant-pathogen interaction | 26 (13.61%) | 155 (3.53%) | 4.98E-08 | ko04626 | |
| Le48h vs. Le0h | Plant-pathogen interaction | 21 (13.04%) | 155 (3.53%) | 7.89E-06 | ko04626 |
| Plant hormone signal transduction | 25 (15.53%) | 262 (5.97%) | 2.06E-04 | ko04075 |
KEGG pathways with Q-values ≤0.05 were considered significantly enriched in DEGs.